BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 7838523)

  • 21. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.
    Peeper DS; Keblusek P; Helin K; Toebes M; van der Eb AJ; Zantema A
    Oncogene; 1995 Jan; 10(1):39-48. PubMed ID: 7824278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
    Kim TA; Ravitz MJ; Wenner CE
    J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
    Ahmad N; Gupta S; Mukhtar H
    Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
    Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
    Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product.
    Ishii T; Shimizu M; Kanayama Y; Nakada S; Nojima H; Oda K
    Exp Cell Res; 1993 Oct; 208(2):407-14. PubMed ID: 8375470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model of the G1 phase of the cell cycle incorporating cyclin E/cdk2 complex and retinoblastoma protein.
    Obeyesekere MN; Herbert JR; Zimmerman SO
    Oncogene; 1995 Sep; 11(6):1199-205. PubMed ID: 7566981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation.
    Rieber M; Rieber MS
    Cell Growth Differ; 1994 Dec; 5(12):1339-46. PubMed ID: 7696182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells.
    Wang QM; Feinman R; Kashanchi F; Houghton JM; Studzinski GP; Harrison LE
    Clin Cancer Res; 2000 Jul; 6(7):2951-8. PubMed ID: 10914745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of E2F1 in mesangial cell proliferation in vitro.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A complex between E2F and the pRb-related protein p130 is specifically targeted by the simian virus 40 large T antigen during cell transformation.
    Wolf DA; Hermeking H; Albert T; Herzinger T; Kind P; Eick D
    Oncogene; 1995 Jun; 10(11):2067-78. PubMed ID: 7784051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA; Saunders AM; Chellappan SP; Grant S
    Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins.
    Yang R; Müller C; Huynh V; Fung YK; Yee AS; Koeffler HP
    Mol Cell Biol; 1999 Mar; 19(3):2400-7. PubMed ID: 10022926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformation by v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factors.
    Clark W; Gillespie DA
    Cell Growth Differ; 1997 Apr; 8(4):371-80. PubMed ID: 9101083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.